临床研究

眼眶内壁减压联合脂肪减压对甲状腺相关眼病限制性斜视的影响

  • 胡丰 ,
  • 叶云燕 ,
  • 孔巧
展开
  • 宁波市医疗中心李惠利医院眼科 (浙江 宁波 315040 )

收稿日期: 2025-01-06

  网络出版日期: 2025-04-23

基金资助

宁波市眼科临床医学研究中心开放基金(2023-Z6)

Effect of endoscopic transethmopath orbital wall decompression combined with fat orbital decompression on restrictive strabismus in thyroid⁃associated ocular diseases

  • Feng HU ,
  • Yunyan YE ,
  • Qiao KONG
Expand
  • Department of Ophthalmology,Ningbo Medical Center LiHuili Hospital,Ningbo 315040,Zhejiang,China

Received date: 2025-01-06

  Online published: 2025-04-23

摘要

目的 评估内窥镜下经筛径路眶内壁减压(endoscopic transethmoidal orbital wall decompression, ETMOWD)联合脂肪减压(fat orbital decompression, FROD)术对甲状腺相关眼病(thyroid-associated ophthalmopathy, TAO)限制性斜视的影响效果。 方法 回顾性系列病例研究,选取2021年12月至2024年8月确诊为TAO的病例,按照是否行眶减压术,分成眶减压组(OD组)和非眶减压组(NOD组),比较两组之间围手术期的一般资料,斜视类型、眼球运动限制程度、眼肌后徙量及手术效果,并对OD组评估ETMOWD联合脂肪减压术式对斜视的影响。手术成功的定义为复视消失,术后斜视度≤ 5 PD。 结果 共计65 例纳入分析,其中OD组40例、NOD组25例,所有患者的甲状腺指标均在正常范围内,活动性评分均≤ 3分,处于静止期内,两组间的一般资料及术前斜视类型,包括水平和垂直斜视度差异无统计学意义(P > 0.05),而OD组眼球运动限制分级、手术次数、手术总肌肉数、水平肌肉数量以及水平肌肉后徙效应量明显高于NOD组,术后所有患者的眼球运动限制程度及复视情况均有明显缓解,ODG组治愈率为70%,NOD组治愈率为72%。并且,OD组经眶减压手术影响,眼压由术前的(19.43 ± 3.9) mmHg降至术后的(15.05 ± 2.2) mmHg(P < 0.001),而水平斜视度与垂直斜视度在术后均有所增加。 结论 与NOD相比,OD组斜视手术的复杂性增加,包括斜视程度、手术次数、总肌肉条数、水平肌条数及水平肌后徙效应量,ETMOWD联合脂肪减压术对水平肌的影响更为显著,但两种治疗方案的长期手术效果相似。

本文引用格式

胡丰 , 叶云燕 , 孔巧 . 眼眶内壁减压联合脂肪减压对甲状腺相关眼病限制性斜视的影响[J]. 实用医学杂志, 2025 , 41(7) : 1018 -1023 . DOI: 10.3969/j.issn.1006-5725.2025.07.013

Abstract

Objective To assess the efficacy of endoscopic transethmoidal orbital wall decompression (ETMOWD) in conjunction with fat removal orbital decompression (FROD) on restrictive strabismus in patients with thyroid?associated ophthalmopathy (TAO). Methods A retrospective case series study was conducted involving patients diagnosed with TAO at our hospital from December 2021 to August 2024. Patients were divided into two groups: the orbital decompression group (OD group) and the non?orbital decompression group (NOD group), based on whether they underwent orbital decompression surgery. The study compared perioperative data, types of strabismus, degree of ocular motility limitation, extent of posterior migration of ocular muscles, and postoperative outcomes between the two groups. Additionally, the effects of ETMOWD combined with FROD on strabismus were evaluated by analyzing changes in relevant indices before and after surgery in the OD group. Results A total of 65 participants were included in the analysis, with 40 in the OD group group and 25 in the NOD group. There was no statistically significant difference in baseline characteristics between the two groups. Preoperative strabismus types, including horizontal and vertical strabismus, did not differ significantly between the OD and NOD groups (P > 0.05). However, the mean preoperative restriction grade of eye movement was significantly higher in the OD group compared to the NOD group. Additionally, the number of surgeries, mean total operated muscles, and number of horizontal muscles were all significantly higher in the OD group than in the NOD group (all P < 0.05), with a notably different effect on horizontal muscle migration between the two groups. The degree of restriction of eye movement and diplopia improved significantly in all patients, with cure rates of 70% in the OD group and 72% in the NOD group. Furthermore, the OD group underwent ETMOWD combined with FROD orbital decompression surgery, which resulted in a decrease in intraocular pressure (IOP) from (19.43 ± 3.9) mmHg preoperatively to (15.05 ± 2.2 mmHg postoperatively (P < 0.001). Both horizontal and vertical strabismus increased after surgery. Conclusions Our results demonstrated that, compared with the NOD group, the OD group exhibited increased complexity in strabismus surgery, as evidenced by a higher number of operations, total muscle strips, horizontal muscle strips, and greater migratory effect size of the horizontal muscles. The combination of ETMOWD and FROD effectively reduced exophthalmos, with a more pronounced effect on the medial rectus muscle compared to the vertical muscles. However, the long?term outcomes between the two groups were similar.

参考文献

1 JUREK-MATUSIAK O, BRO?EK-M?DRY E, JASTRZ?BSKA H, et al. Orbital Decompression for Thyroid Eye Disease: Surgical Treatment Outcomes in Endocrinological Assessment [J]. Endokrynol Pol, 2021, 72(6): 609-617. doi:10.5603/ep.a2021.0078
2 BARTALENA L, KAHALY G J, BALDESCHI L, et al. The 2021 European Group on Graves' Orbitopathy (Eugogo) Clinical Practice Guidelines for the Medical Management of Graves' Orbitopathy [J]. Eur J Endocrinol, 2021, 185(4): G43-G67.
3 郜梦媛, 涂云海, 吴文灿. 甲状腺相关性眼病眼眶减压术新进展 [J]. 现代实用医学, 2023, 35(5): 565-568.
4 TU Y, XU M, KIM A D, et al. Modified Endoscopic Transnasal Orbital Apex Decompression in Dysthyroid Optic Neuropathy [J]. Eye Vis (Lond), 2021, 8(1): 19. doi:10.1186/s40662-021-00238-2
5 涂云海, 徐明娜, 吴文灿. 甲状腺相关性眼病内镜微创减压术的历史与展望 [J]. 中华眼视光学与视觉科学杂志, 2022, 24(9): 649-654.
6 孙柔, 周慧芳. 内镜辅助下经鼻入路眼眶减压术的研究进展 [J]. 上海交通大学学报(医学版), 2021, 41(12): 1691-1697.
7 WU W, SELVA D, BIAN Y, et al. Endoscopic Medial Orbital Fat Decompression for Proptosis in Type 1 Graves Orbitopathy [J]. Am J Ophthalmol, 2015, 159(2): 277-284. doi:10.1016/j.ajo.2014.10.029
8 LV Z, SELVA D, YAN W, et al. Endoscopical Orbital Fat Decompression with Medial Orbital Wall Decompression for Dysthyroid Optic Neuropathy [J]. Curr Eye Res, 2016, 41(2): 150-158. doi:10.3109/02713683.2015.1008640
9 ROOTMAN D B. Orbital Decompression for Thyroid Eye Disease [J]. Surv Ophthalmol, 2018, 63(1): 86-104. doi:10.1016/j.survophthal.2017.03.007
10 RODA M, VALSECCHI N, DI GERONIMO N, et al. Long-term Surgical Outcome and Impact on Daily Life Activities of Strabismus Surgery in Thyroid-Associated Ophthalmopathy with and without Previous Orbital Decompression [J]. Head Face Med, 2024, 20(1): 22. doi:10.1186/s13005-024-00423-3
11 SCARABOSIO A, SURICO P L, SINGH R B, et al. Thyroid Eye Disease: Advancements in Orbital and Ocular Pathology Management [J]. J Pers Med, 2024, 14(7):776. doi:10.3390/jpm14070776
12 LAI K K, ABDULLA ALJUFAIRI F M ALI, SEBASTIAN J U, et al. Euthyroid Graves' Ophthalmopathy in a Chinese Population: A Cross-Sectional Follow-Up Study [J]. Eur J Ophthalmol, 2024, 34(5): 1432-1427. doi:10.1177/11206721241229470
13 LEE J K S, HSIEH C, WEI Y H, et al. The Impact of Orbital Bony or Fat Decompression on the Outcome of Strabismus Surgery in Patients with Graves' Ophthalmopathy [J]. J Formos Med Assoc, 2019, 118(1 Pt 3): 387-394. doi:10.1016/j.jfma.2018.06.009
14 ZHU S, DENG R, WU J, et al. Analysis of Added Postoperative Diplopia After Transnasal Endoscopic Inferomedial Wall Decompression for Thyroid-Associated Ophthalmopathy [J]. J Craniofac Surg, 2024. doi: 10.1097/SCS.0000000000010919 .
15 AKBARI M R, MIRMOHAMMADSADEGHI A, MAHMOUDZADEH R, et al. Management of Thyroid Eye Disease-related Strabismus [J]. J Curr Ophthalmol, 2020, 32(1): 1-13. doi:10.1016/j.joco.2019.10.002
16 QAHTANI E S AL, ROOTMAN J, KERSEY J, et al. Clinical Pearls and Management Recommendations for Strabismus Due to Thyroid Orbitopathy [J]. Middle East Afr J Ophthalmol, 2015, 22(3): 307-311. doi:10.4103/0974-9233.159731
17 OEVERHAUS M, FISCHER M, HIRCHE H, et al. Tendon Elongation with Bovine Pericardium in Patients with Severe Esotropia after Decompression in Graves' Orbitopathy-efficacy and Long-term Stability [J]. Strabismus, 2018, 26(2): 62-70. doi:10.1080/09273972.2018.1450430
18 LYU I J, LEE J Y, KONG M, et al. Surgical Responses of Medial Rectus Muscle Recession in Thyroid Eye Disease-Related Esotropia [J]. PLoS One, 2016, 11(1): e0146779. doi:10.1371/journal.pone.0146779
19 HUELIN F J, DEL VALLE J M R, SALES-SANZ M, et al. Postoperative Drift and Dose-Response of Strabismus Surgery in Thyroid Eye Disease: Predicting Desired Outcomes with Intraoperative Adjustable Sutures [J]. Can J Ophthalmol, 2024, 59(1): e53-e60. doi:10.1016/j.jcjo.2022.10.022
20 CESTARI D M, FREIRE M V, CHUN B Y. Vertical Rectus Muscle Recession Versus Combined Vertical and Horizontal Rectus Muscle Recession in Patients with Thyroid Eye Disease and Hypotropia [J]. J aapos, 2018, 22(4): 257-261. doi:10.1016/j.jaapos.2018.04.007
21 AKBARI M, BAYAT R, MIRMOHAMMADSADEGHI A, et al. Strabismus Surgery in Thyroid-associated Ophthalmopathy; Surgical Outcomes and Surgical Dose Responses [J]. J Binocul Vis Ocul Motil, 2020, 70(4): 150-156. doi:10.1080/2576117x.2020.1792029
22 史婧. 术前眼眶减压对甲状腺相关眼病中斜视患者矫正术疗效的影响 [J]. 大医生, 2024, 9(2): 139-141.
23 DALLAN I, CRISTOFANI-MENCACCI L, FIACCHINI G, et al. Functional Outcomes and Complications in Refractory Dysthyroid Optic Neuropathy Management: Experience with 3 Different Surgical Protocols [J]. Am J Otolaryngol, 2022, 43(3): 103451. doi:10.1016/j.amjoto.2022.103451
24 TIAN P, ZENG P, ZHANG H, et al. Balanced Medial-Lateral Wall vs Selective 3-Wall Orbital Decompression for Sight-Threatening Graves's Orbitopathy: A Clinical Retrospective Cohort Study From 2016 To 2022 [J]. Eur Arch Otorhinolaryngol, 2024, 281(9):4807-4815. doi:10.1007/s00405-024-08589-x
文章导航

/